|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.190 USD | -0.95% |
|
-1.41% | -3.46% |
| 25/02 | PolyPid Ltd. Auditor Raises 'Going Concern' Doubt | CI |
| 11/02 | PolyPid Ltd., Q4 2025 Earnings Call, Feb 11, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| POLYPID LTD. | Other Pharmaceuticals | -0.95% | -1.41% | -3.46% | +49.11% | -98.65% | 8Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- PYPD Stock
- Charts PolyPid Ltd.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition